-- 週三,近期公佈財報的日本股市普遍上漲,與大盤走勢一致,其中獲利成長強勁且前景樂觀的公司領漲。 Money Forward(東京證券交易所代碼:3994)公佈第一季業績後股價飆升17%,扭虧為盈,實現歸屬於母公司股東的利潤18.3億日元,去年同期虧損11.2億日元。營收成長25.3%至146.7億日圓。該公司預計全年歸屬於母公司股東的利潤將出現虧損,營收預計在534億至575.5億日圓之間。 Baycurrent(東京證券交易所代碼:6532)公佈全年業績後股價上漲14%,歸屬於母公司股東的利潤增長23%至378.4億日元,營收增長27.8%至1483.3億日元。該公司預測下一財年歸屬於母公司股東的利潤為481億日元,營業收入為1,900億日圓。 同時,東邦株式會社公佈全年業績後股價下跌5%。歸屬於母公司股東的利潤從433.6億日圓增至517.7億日元,營業收入增長15.2%至3606.6億日元,但該公司預測下一財年歸屬於母公司股東的利潤為410億日元,營業收入為3450億日元。
Related Articles
Clinuvel Unlikely to Seek Scenesse's Vitiligo Approval Before Phase 3 Completion, Says Jefferies
Clinuvel Pharmaceuticals (ASX:CUV) is unlikely to seek regulatory approval for Scenesse in vitiligo until the Phase 3 CUV105 and CUV107 clinical trials are completed, according to a Friday Jefferies note.The company said on Friday that the European Medicines Agency (EMA) has proposed evaluating the company's Scenesse drug for the treatment of systemic vitiligo based on a "totality of evidence" regulatory approach.Jefferies said that the EMA's decision is a positive for the company because of the high unmet medical need for Vitiligo treatment.The investment firm has pushed back its revenue expectations from Scenesse in vitiligo, which is now expected to begin in the second half of fiscal 2029 rather than fiscal 2028.Jefferies kept a buy rating on Clinuvel and cut its price target to AU$39.20 from AU$40.50.
ASX Preview: Australian Shares Set to Open Flat on Stalled US-Iran Talks; Origin Energy Reports Lower March Quarter Production
Australian shares are set to open flat on Monday, as oil prices climbed almost 2% following stalled US-Iran peace negotiations and restricted flows through the Strait of Hormuz, tightening global supply and pushing Brent crude above $107 a barrel.On April 25, the S&P 500 and the Nasdaq Composite rose 0.8% and 1.6%, respectively, while the Dow Jones Industrial Average fell 0.2%.In the macroeconomy, investors are eyeing the release of Australia's consumer price index report on Wednesday.In corporate news, Origin Energy (ASX:ORG) reported March quarter production of 164.5 petajoules, down from 167.1 petajoules a year earlier, according to a Monday filing with the Australian bourse.IperionX's (ASX:IPX) titanium powder production operations in Virginia, US, transitioned to an around-the-clock production schedule during the March quarter, advancing from commissioning to continuous operations, according to a Monday filing with the Australian bourse.Australia's benchmark index fell 0.1% or 6.9 points to close at 8,786.50 on April 24.
Cobre Appoints Chief Financial Officer
Cobre (ASX:CBE) has appointed Kaveen Bachoo as chief financial officer, effective April 28, according to a Monday filing with the Australian bourse.Bachoo has over 20 years of finance leadership experience in the mining sector, including executive positions at Glencore.